<SEC-DOCUMENT>0001256071-24-000013.txt : 20241106
<SEC-HEADER>0001256071-24-000013.hdr.sgml : 20241106
<ACCEPTANCE-DATETIME>20241106195345
ACCESSION NUMBER:		0001256071-24-000013
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20241106
DATE AS OF CHANGE:		20241106

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KAZIA THERAPEUTICS LTD
		CENTRAL INDEX KEY:			0001075880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-50612
		FILM NUMBER:		241432687

	BUSINESS ADDRESS:	
		STREET 1:		THREE INTERNATIONAL TOWERS LEVEL 24,
		STREET 2:		300 BARANGAROO AVENUE
		CITY:			SYDNEY NSW
		STATE:			C3
		ZIP:			2000
		BUSINESS PHONE:		01161298780088

	MAIL ADDRESS:	
		STREET 1:		THREE INTERNATIONAL TOWERS LEVEL 24,
		STREET 2:		300 BARANGAROO AVENUE
		CITY:			SYDNEY NSW
		STATE:			C3
		ZIP:			2000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVOGEN LTD
		DATE OF NAME CHANGE:	19981228

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PLATINUM INVESTMENT MANAGEMENT LTD
		CENTRAL INDEX KEY:			0001256071
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		C/O PLATINUM ASSET MANAGEMENT
		STREET 2:		LEVEL 8, 7 MACQUARIE PLACE
		CITY:			SYDNEY AUSTRALIA 2000
		STATE:			C3
		ZIP:			00000
		BUSINESS PHONE:		61292557533

	MAIL ADDRESS:	
		STREET 1:		C/O PLATINUM ASSET MANAGEMENT
		STREET 2:		LEVEL 8, 7 MACQUARIE PLACE
		CITY:			SYDNEY AUSTRALIA 2000
		STATE:			C3
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PLATINUM ASSET MANAGEMENT LTD
		DATE OF NAME CHANGE:	20030722
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>KaziaTherapeutics21.txt
<DESCRIPTION>SC 13G
<TEXT>



Schedule 13G


Name of issuer: Kazia Therapeutics Ltd

	Title of class of securities: Sponsored ADR

	Cusip: 48669G105

	Date of event which requires filing: 09/30/2024

	Rule 13d-1(b)

	1.	Platinum Investment Management Limited

	2.	(b)

	3.

	4.	Sydney Australia

	5.	Platinum Investment Management Limited
		0 	(0%)
		Note:Combined total of underlying managed funds


	6.	N/A

	7.	Platinum Investment Management Limited
		0	(0%)
		Note:Combined total of underlying managed funds

	8.	N/A

	9.	0

	10.	No

	11.	0%

	12.	IA



Item 1.

(a) 	Kazia Therapeutics Ltd

(b)     Three International Towers,
	Level 24, 300 Barangaroo Avenue,
	SYDNEY, NSW, Australia, 2000



Item 2.

(a) Platinum Investment Management Limited

(b) Level 8, 7 Macquarie Place
    Sydney NSW 2000
    Australia
(c) Australia
(d) Sponsored ADR
(e) 48669G105

Item 3.
(e) An IA in accordance with Section 240.13d-1(b)(1)(ii)(e)

Item 4.

(a) 0
(b) 0%
(c) (i) 0
(ii) 0
(iii) 0
(iv) 0

Item 5
Yes

Item 6
The clients of Platinum Investment Management Ltd including pooled
investment vehicles and other managed accounts have the right to
receive or power to direct the receipt of dividends from, and the
proceeds from the sale of, Kazia Therapeutics Ltd.

Item 7
N/A

Item 8
N/A

Item 9
N/A



Item 10
(a) By signing below, I certify that to the best of my knowledge and
belief, the securities referred to above were acquired and are held
in the ordinary course of business and were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.
(b) N/A


After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information
set forth in this statement is true, complete and correct.

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
